Treatment of mild headache in disabled migraine sufferers: Results of the spectrum study

Headache

Volumn 40, Issue 10, 2000, Pages 792-797

  Cady, R K ^a   Lipton, R B ^b,c   Hall, C ^d   Stewart, W F ^e   O'Quinn, S ^f   Gutterman, D ^f  

^a HEADACHE CARE CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Innovative Medical Research   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Disability; Migraine; Mild; Spectrum; Sumatriptan

Indexed keywords

ANTIMIGRAINE AGENT; SEROTONIN AGONIST; SUMATRIPTAN;

ACUTE DISEASE; ADULT; ANALYTIC METHOD; ANTINOCICEPTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MALE; METHODOLOGY; MIGRAINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYMPTOM; TREATMENT OUTCOME; WORK DISABILITY;

ADMINISTRATION, ORAL; ADULT; DISABLED PERSONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RECURRENCE; SUMATRIPTAN; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0034527433     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2000.00144.x     Document Type: Article

References (4)

1. Tfelt-Hansen P. How to define the best efficacy parameters for migraine. Cephalalgia. 1997;17(suppl 17):6-8.
2. Pilgrim AJ. Early-phase clinical trials in migraine: efficacy, safety and dose-finding. Cephalalgia. 1995; 15(suppl):10-13.
3. Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol. 1991;31:295-299.
4. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia. 1991;11:1-12.